Concepedia

Ruowei Mo

RM

Statistics

Publications

12

Citations

580

H-Index

12

Active since

1998

Affiliations

Bristol-Myers Squibb (United States)(Current)

Novartis (United States)

Ruowei Mo is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1998–2020

12

Publications

12

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

, , +10

Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors

Robert J. Cherney, Ruowei Mo, Dayton T. Meyer et al. · Journal of Medicinal Chemistry · 2004 · 94 citations · Full text

, , +17

Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore

James McNulty, Justin Mao, Romelo Gibe et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 78 citations

, , +5

Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists

Robert J. Cherney, Ruowei Mo, Dayton T. Meyer et al. · Journal of Medicinal Chemistry · 2008 · 44 citations · Full text

, , +17

Diastereoselective intramolecular nitroaldol entry to lycoricidine alkaloids

James McNulty, Ruowei Mo · Chemical Communications · 1998 · 42 citations

, , +4

1–5 of 12